Join us for our Life Sciences Academy event this September to hear from our UK Life Sciences experts discussing some of the key issues the industry is facing.
This will be a half-day morning event held at our London office with a mix of sessions, presented by our experts in M&A, Regulatory, Data Protection and Intellectual Property, finishing off with a networking lunch.
08:30 - 09:00 | Breakfast and registration |
09:00 - 09:30 |
Dealmaking in Life Sciences – latest trends and issues James Baillieu We will be looking at recent trends and issues in life sciences dealmaking, including a review of how the new National Security & Investment Act is impacting dealmaking. |
09:30 - 10:00 |
UK data protection reform – winners, losers and what to watch within the life sciences sector Gabriel Voisin We will be walking through the UK government’s proposals and what the new data protection bill announced in the Queen’s Speech means for organisations with the life sciences sector. |
10:00- 10:30 |
Recruitment and retention of scientific talent in a COVID-impacted world Emily Clark and Rob Briggs We will be discussing the new normal for many life sciences and healthcare clients, which includes remote and hybrid working, protecting business interests and flexible and contingent labour structures. |
10:30- 10:50 | Break |
10:50 - 11:20 |
Unitary Patents & the Unified Patent Court – nearly open for business and still relevant to UK business Eleanor Root We will update you with the current status of this major development in patent law, including the outlook and consideration of the UK angles. |
11:20 - 11:50 |
Deviation or alignment? Sally Shorthose We will provide you with an overview on the current regulatory environment for UK pharma and medical devices companies. |
11:50 - 12:30 |
An update on the Government's life sciences policy agenda Dr. Martin Turner at the BioIndustry Association |
12:30 - 14:00 | Networking lunch |
Address
Bird & Bird LLP